experimental psychosis
Recently Published Documents


TOTAL DOCUMENTS

21
(FIVE YEARS 1)

H-INDEX

9
(FIVE YEARS 0)

Author(s):  
Ismail O. Ishola ◽  
Benneth Ben-Azu ◽  
Oluwatosin A. Adebayo ◽  
Abayomi M. Ajayi ◽  
Iziegbe Lisa Omorodion ◽  
...  

2016 ◽  
Vol 363 (3) ◽  
pp. 825-825
Author(s):  
Malwina Lisek ◽  
Tomasz Boczek ◽  
Bozena Ferenc ◽  
Ludmila Zylinska

2015 ◽  
Vol 363 (3) ◽  
pp. 609-620 ◽  
Author(s):  
Malwina Lisek ◽  
Tomasz Boczek ◽  
Bozena Ferenc ◽  
Ludmila Zylinska

2012 ◽  
Vol 63 (6) ◽  
pp. 1161-1171 ◽  
Author(s):  
Manavi Chatterjee ◽  
Rajkumar Verma ◽  
Surajit Ganguly ◽  
Gautam Palit

2011 ◽  
Vol 37 (4) ◽  
pp. 759-770 ◽  
Author(s):  
Manavi Chatterjee ◽  
Seema Singh ◽  
Reena Kumari ◽  
Anil Kumar Verma ◽  
Gautam Palit

2011 ◽  
Vol 2 (1) ◽  
pp. 47-53
Author(s):  
A. L. Drozdov ◽  
E. M. Demchenko ◽  
A. Ejjyad ◽  
O. P. Nerush

Data obtained showed that using of neuroleptics in conditions of experimental psychosis was accompanied by the decreasing of mobility, investigative behavior and emotionality in experimental animals more than in intact ones. Asopposed to that, the action of atypical antipsychotic drug – sulpiride was characterized by the anxiety decreasing but the mobility increasing. The nootropic agents resulted in increasing of motor and emotional activity. The established pharmacological effects of neuroleptics, antidepressants and nootropic agents may use in clinical practice for treatment optimization of the patients with mental disability including schizophrenia.


Sign in / Sign up

Export Citation Format

Share Document